Vanguard Portfolio Management’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.25M Buy
94,414
+30,807
+48% +$905K ﹤0.01% 2572
2026
Q1
$1.97M Buy
+63,607
New +$1.57M ﹤0.01% 2602

Other funds holding TECX

Vanguard Portfolio Management's TECX Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Tectonic Therapeutic (TECX) stake by 48% in Q2 2026, buying an estimated $905K and bringing the position to 94,414 shares worth $3.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2572.

Vanguard Portfolio Management first reported a position in TECX in Q1 2026 and has held it in 2 quarters since. 122 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Vanguard Portfolio Management held 94,414 shares of Tectonic Therapeutic worth $3.25M as of Q2 2026.
  • Vanguard Portfolio Management bought 30,807 Tectonic Therapeutic shares in Q2 2026, an estimated $905K.
  • Tectonic Therapeutic made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2572 holding.
  • Vanguard Portfolio Management first reported a position in Tectonic Therapeutic in Q1 2026 and has held it in 2 quarters since.
  • 122 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.